InsiderClue
Insiders · Profile

Leggett Thomas

Chief Financial Officer at Stoke Therapeutics · Chief Financial Officer at Black Diamond Therapeutics. Filing since 14 Sep 2020. CIK 0001774690

STOK Stoke Therapeutics, Inc. Chief Financial Officer · 2 trades BDTX Black Diamond Therapeutics, Inc. Chief Financial Officer · 5 trades
Company
Date
Role
Action
Shares
Amount
Of holding
STOK Stoke Therapeutics, Inc.
18 Mar 2026
Chief Financial Officer
Sold at will
2,382
$74.66K
19.0%
STOK Stoke Therapeutics, Inc.
17 Mar 2026
Chief Financial Officer
Sold at will
2,196
$72.48K
14.9%
BDTX Black Diamond Therapeutics, Inc.
8 Jan 2021
Chief Financial Officer
Sold, plan not stated
3,000
$101.82K
100%
BDTX Black Diamond Therapeutics, Inc.
8 Dec 2020
Chief Financial Officer
Sold, plan not stated
3,000
$101.33K
100%
BDTX Black Diamond Therapeutics, Inc.
9 Nov 2020
Chief Financial Officer
Sold, plan not stated
3,000
$98.89K
100%
BDTX Black Diamond Therapeutics, Inc.
8 Oct 2020
Chief Financial Officer
Sold, plan not stated
3,000
$100.58K
100%
BDTX Black Diamond Therapeutics, Inc.
14 Sep 2020
Chief Financial Officer
Sold, plan not stated
3,000
$93.00K
100%
7 decisions on file.